Cytodyn Inc (CYDY)

[jimmy667]

I believe the FDA will shift gears from foot dragging on the HIV indication to all deliberate speed on the critical Covid indication. The question now is likely partly ethical considerations of which patients get it first using the current supply. I expect the results and EUA will be announced together and CYDY will go on a share price run of successive up gaps.
CytoDyn has a quirky CEO and has led many to underestimate the value of the company due to set backs.
One should realize the reluctance of the FDA in HIV was due to the novel MOA so very different from current approaches in HIV and only an incremental improvement over current treatments. In critical Covid
only Dexamethasone and the prognosis is poor with unacceptable fatality and ICU rates. Leronlimab may not be a "Silver Bullet" but it is critically needed effective ammunition for doctors and hospitals in the critical Covid patients. Those Leronlimab shots can't miss because of the safety profile.